Literature DB >> 26516792

Regulation of RIPK1's cell death function by phosphorylation.

Yves Dondelinger1,2, Peter Vandenabeele1,2, Mathieu J M Bertrand1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26516792      PMCID： PMC4825752          DOI： 10.1080/15384101.2015.1112688

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.

Authors:  Yves Dondelinger; Sandrine Jouan-Lanhouet; Tatyana Divert; Emilie Theatre; John Bertin; Peter J Gough; Piero Giansanti; Albert J R Heck; Emmanuel Dejardin; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Mol Cell       Date:  2015-09-03       Impact factor: 17.970

2.  Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis.

Authors:  Thomas McQuade; Youngsik Cho; Francis Ka-Ming Chan
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

Review 3.  The two faces of receptor interacting protein kinase-1.

Authors:  Ricardo Weinlich; Douglas R Green
Journal:  Mol Cell       Date:  2014-11-20       Impact factor: 17.970

Review 4.  Necroptosis and its role in inflammation.

Authors:  Manolis Pasparakis; Peter Vandenabeele
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

5.  Identification of RIP1 kinase as a specific cellular target of necrostatins.

Authors:  Alexei Degterev; Junichi Hitomi; Megan Germscheid; Irene L Ch'en; Olga Korkina; Xin Teng; Derek Abbott; Gregory D Cuny; Chengye Yuan; Gerhard Wagner; Stephen M Hedrick; Scott A Gerber; Alexey Lugovskoy; Junying Yuan
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

6.  NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

Authors:  L Boutaffala; M J M Bertrand; C Remouchamps; G Seleznik; F Reisinger; M Janas; C Bénézech; M T Fernandes; S Marchetti; F Mair; C Ganeff; A Hupalowska; J-E Ricci; B Becher; J Piette; P Knolle; J Caamano; P Vandenabeele; M Heikenwalder; E Dejardin
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

7.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.

Authors:  Peter V Hornbeck; Jon M Kornhauser; Sasha Tkachev; Bin Zhang; Elzbieta Skrzypek; Beth Murray; Vaughan Latham; Michael Sullivan
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971
  7 in total
  8 in total

Review 1.  Initiation and execution mechanisms of necroptosis: an overview.

Authors:  Sasker Grootjans; Tom Vanden Berghe; Peter Vandenabeele
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

Review 2.  The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.

Authors:  Eunjin Ju; Kyeong Ah Park; Han-Ming Shen; Gang Min Hur
Journal:  Exp Mol Med       Date:  2022-09-28       Impact factor: 12.153

3.  Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure.

Authors:  Nadine Gehrke; Marcus A Wörns; Amrit Mann; Nadine Hövelmeyer; Ari Waisman; Beate K Straub; Peter R Galle; Jörn M Schattenberg
Journal:  Cell Death Dis       Date:  2022-05-31       Impact factor: 9.685

4.  Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.

Authors:  Louise V Webb; Alessandro Barbarulo; Jelle Huysentruyt; Tom Vanden Berghe; Nozomi Takahashi; Steven Ley; Peter Vandenabeele; Benedict Seddon
Journal:  Immunity       Date:  2019-02-05       Impact factor: 31.745

Review 5.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

6.  Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma.

Authors:  Yinfei Tan; Eleonora Sementino; Mitchell Cheung; Suraj Peri; Craig W Menges; Anna-Mariya Kukuyan; Ting Zhang; Vladimir Khazak; Lauren A Fox; Eric A Ross; Suresh Ramanathan; Suresh C Jhanwar; Raja M Flores; Siddharth Balachandran; Joseph R Testa
Journal:  Clin Cancer Res       Date:  2020-11-17       Impact factor: 13.801

Review 7.  Necroptosis in Immuno-Oncology and Cancer Immunotherapy.

Authors:  Jenny Sprooten; Pieter De Wijngaert; Isaure Vanmeerbeerk; Shaun Martin; Peter Vangheluwe; Susan Schlenner; Dmitri V Krysko; Jan B Parys; Geert Bultynck; Peter Vandenabeele; Abhishek D Garg
Journal:  Cells       Date:  2020-08-01       Impact factor: 6.600

Review 8.  The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer.

Authors:  Laura Della Torre; Angela Nebbioso; Hendrik G Stunnenberg; Joost H A Martens; Vincenzo Carafa; Lucia Altucci
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.